Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $700

Benzinga · 2d ago
Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $665 to $700.